Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Leases (2019 - 2025)

Arcadia Biosciences filings provide 7 years of Leases readings, the most recent being $10000.0 for Q2 2025.

  • On a quarterly basis, Leases fell 98.05% to $10000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $10000.0, a 98.05% decrease, with the full-year FY2024 number at $137000.0, down 82.7% from a year prior.
  • Leases hit $10000.0 in Q2 2025 for Arcadia Biosciences, down from $19000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $6.4 million in Q2 2021 to a low of $10000.0 in Q2 2025.
  • Median Leases over the past 5 years was $1.5 million (2023), compared with a mean of $1.9 million.
  • Biggest five-year swings in Leases: rose 13.61% in 2021 and later tumbled 98.05% in 2025.
  • Arcadia Biosciences' Leases stood at $3.1 million in 2021, then crashed by 40.02% to $1.8 million in 2022, then plummeted by 57.14% to $792000.0 in 2023, then plummeted by 82.7% to $137000.0 in 2024, then plummeted by 92.7% to $10000.0 in 2025.
  • The last three reported values for Leases were $10000.0 (Q2 2025), $19000.0 (Q1 2025), and $137000.0 (Q4 2024) per Business Quant data.